Oxford BioMedica PLC (OXBDF)

[marcusl2]

"It's rare to hear regulators refer to the data as 'the most exciting thing I've seen in my lifetime.' I feel exactly the same way," said Maus. Upon learning about the decision, Maus said, "our whole lab was skipping and almost in tears at the same time."
HTTPS://www.aaas.org/news/personalized-precision-immunotherapy-tested-brain-tumors

"I am firmly convinced that CAR T cells and other immunotherapies have a chance to be a major breakthrough for glioblastoma," said Donald O'Rourke, a professor of neurosurgery at the University of Pennsylvania Perelman School of Medicine and first author on the paper.
"We were all taught for decades that the brain is an 'immunoprivileged' site and that immunotherapy would not work in the brain," said O'Rourke. "That is clearly old dogma that is not accurate."